The potential role of platelet microparticles in atherosclerosis

Thrombosis and Haemostasis

Volumn 94, Issue 3, 2005, Pages 488-492

  Tan, Kiat T ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Angiogenesis; Atherosclerosis; Platelet microparticles; Platelets; Thrombosis

Indexed keywords

CELL MEMBRANE PROTEIN; LIPID;

ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL VACUOLE; HUMAN; INFLAMMATION; NONHUMAN; PARTICLE SIZE; PATHOGENESIS; PLATELET MICROPARTICLE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

ANIMALS; ARTERIOSCLEROSIS; BLOOD COAGULATION; BLOOD PLATELETS; CELL MEMBRANE; DATABASES, BIBLIOGRAPHIC; ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE LIPIDS; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET ACTIVATION; THROMBOSIS;

EID: 24944453206     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-03-0201     Document Type: Review

References (43)

1. Massberg S, Brand K, Gruner S et al. A critical role of platelet adhesion in the initiation of the atherosclerotic lesions formation. J Exp Med 2002; 196: 887-96.
2. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-7.
3. Siljander P, Carpen O, Lassila R. Platelet derived microparticles associate with fibrin during thombosis. Blood 1996; 87: 4651-63.
4. Lee YJ, Jy W, Horstman LL et al. Elevated platelet microparticles in transient ischaemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 1993; 72: 295-304.
5. Nomura S, Uehata S, Saito S et al. Enzyme immunoassay detection of platelet derived microparticles and RANTES in acute coronary syndromes. Thromb Haemost 2003; 89: 506-12.
6. Zeiger F, Stephan S, Hoheisel G et al. P-selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 2000; 11: 723-8.
7. Tan KT, Tayebjee MH, Lynd C et al. Platelet microparticles and soluble P-selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med 2005; 37: 61-6.
8. Bernal-Mizrachi L, Jy W, Jimenez JJ et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962 -70.
9. Tan KT, Tayebjee MH, MacFadyen R et al. Elevated platelet microparticles in stable coronary disease are unrelated to disease severity or to indices of inflammation. Platelets 2005; (in press)..
10. Shouzu A, Nomura S, Omoto S et al. Effect of ticlopidine on monocyte-derived microparticles and activated platelet markers in diabetes mellitus. Clin Appl Thromb Hemost 2004; 10: 167-73.
11. Preston RA, Jy W, Jimenez JJ et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-7.
12. Heijnen HF, Schiel AE, Fijnheer R et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94: 3791-99.
13. Yano Y, Kambayashi J, Shiba E et al. The role of protein phosphorylation and cytoskeletal reorganisation in microparticle formation from the platelet plasma membrane. Biochim J 1994; 299: 303-8.
14. Tans G, Rosing J, Thomassen MC et al. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet derived microparticles. Blood 1991: 77; 2641-8.
15. Barry OP, Pratico D, Savani RC et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136-44.
16. English D, Garcia JG, Brindley DN. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc Res 2001; 49: 588-99.
17. Muller I, Klocke A, Alex M et al. Intravascular tissue factor initiates coagulation via ciculating microvesicles and platelets. FASEB J 2003; 17: 476-8.
18. Chou J, Mackman N, Merill-Skoloff G et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190-97.
19. Day SM, Reeve JL, Pedersen B et al. Macrovascular thrombosis is driven by tissue factor derived primarily from blood vessel wall. Blood 2005; 105: 192-8.
20. Biro E, Sturk-Maquelin KN, Vogel GM et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1: 2561-8.
21. Zwaal RF, Comfurius P, Bevers EM. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 2004; 1636: 119-28.
22. Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993; 268: 71711-8.
23. Munnix IC, Harmsma M, Giddings JC et al. Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thromb Haemost 2003; 89: 687-95.
24. Castaman G, Yu-Feng L, Battistin E et al. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997; 96: 458-63.
25. Podor TJ, Singh D, Chindemi P et al. Vimentin exposed on activated platelets and platelet microparticles localises vitronectin and plasminogen activator inhibitor complexes on their surface. J Biol Chem 2002; 277: 7529-39.
26. Horrevoets AJ. Plasminogen activator inhibitor 1: in vitro activities and clinical relevance. Br J Haematol 2004; 125; 12-23.
27. Booth NA, Simpson AJ, Croll A et al. Plasminogen activator inhibitor in plasma and platelets. Br J Haematol 1988; 70: 327-33.
28. Salonen EM, Vaheri A, Pollanen J et al. Interaction of plasminogen activator inhibitor with vitronectin. J Biol Chem 1989; 264: 6339-43.
29. Miles LA, Ginsberg MH, White JG et al. Plasminogen interacts with human platelets through two distinct mechanisms. J Clin Invest 1986; 77: 2001-9.
30. Merten M, Pakala R, Thiagarajan P et al. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999; 99: 2577-82.
31. Gawaz M, Neumann FJ, Dickfield T et al. Vitronectin receptor mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 1997; 96: 1809-18.
32. Barry OP, Pratico D, Lawson JA et al. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118-27.
33. Tan KT, Lip GY. Platelets, atherosclerosis and the endothelium: new therapeutic targets? Expert Opin Investig Drugs 2003; 12: 1765-76.
34. Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med 1999; 340: 115-26.
35. Nomura S, Tandon NN, Nakamura T et al. High-shear stress induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells. Atherosclerosis 2001; 158: 277-87.
36. Weber A, Koppen HO, Schror K. Platelet-derived microparticles stimulate coronary artery smooth muscle mitogenesis by a PDGF-independent mechanism. Thromb Res 2000; 98: 461-6.
37. Burger PC, Wagner DD. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-6.
38. Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000; 9: 1317-23.
39. Jy W, Mao WW, Horstman L et al. Platelet microparticles bind, activate, and aggregate neutrophils in vitro. Blood Cells Mol Dis 1995; 21: 217-31.
40. Tan KT, Lip GY, Blann AD. Post-stroke inflammatory response: effects of stroke evolution and outcome. Curr Atheroscler Rep 2003; 5: 245-51.
41. Kim HK, Song KS, Chung JH et al. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004; 124: 376-84.
42. O'Brien K, Allen M, MacDonald T et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945-51.
43. Moulton KS, Heller E, Konerding MA et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularisation and plaque. Circulation 1999; 99: 1726-32.